These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 35841309)
1. A higher tumor volume and undernutrition at diagnosis adversely affect the survival of children with Wilms tumor: A study of 200 patients. Rahiman EA; Trehan A; Jain R; Menon P; Kakkar N; Srinivasan R; Sodhi KS; Saxena AK; Kapoor R; Bansal D Pediatr Blood Cancer; 2022 Nov; 69(11):e29880. PubMed ID: 35841309 [TBL] [Abstract][Full Text] [Related]
2. Postchemotherapy tumor volume as a prognostic indicator in Wilms tumor: A single-center experience from South India. Joseph LL; Boddu D; Srinivasan HN; Regi SS; Antonisamy B; John R; Mathew LG; Totadri S Pediatr Blood Cancer; 2022 Feb; 69(2):e29454. PubMed ID: 34811921 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001. Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556 [TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01. Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263 [TBL] [Abstract][Full Text] [Related]
5. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957 [TBL] [Abstract][Full Text] [Related]
6. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561 [TBL] [Abstract][Full Text] [Related]
7. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols. Groenendijk A; van Tinteren H; Jiang Y; de Krijger RR; Vujanic GM; Godzinski J; Rübe C; Schenk JP; Morosi C; Pritchard-Jones K; Al-Saadi R; Vaidya SJ; Verschuur AC; Ramírez-Villar GL; Graf N; de Camargo B; Drost J; Perotti D; van den Heuvel-Eibrink MM; Brok J; Spreafico F; Mavinkurve-Groothuis AMC Eur J Cancer; 2022 Mar; 163():88-97. PubMed ID: 35042071 [TBL] [Abstract][Full Text] [Related]
8. Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan. Ghafoor T; Bashir F; Ahmed S; Khalil S; Farah T J Pediatr Urol; 2020 Jun; 16(3):375.e1-375.e7. PubMed ID: 32224063 [TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020). Vujanić GM; Mifsud W; Chowdhury T; Al-Saadi R; Pritchard-Jones K; Cancer; 2022 Apr; 128(8):1666-1675. PubMed ID: 35119702 [TBL] [Abstract][Full Text] [Related]
10. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience. Vujanić GM; Graf N; D'Hooghe E; Pritchard-Jones K; Bergeron C; Tinteren HV; Furtwängler R; Pediatr Blood Cancer; 2024 Mar; 71(3):e30852. PubMed ID: 38185745 [TBL] [Abstract][Full Text] [Related]
11. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa. Aronson DC; Hadley GP Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084 [TBL] [Abstract][Full Text] [Related]
12. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Weirich A; Ludwig R; Graf N; Abel U; Leuschner I; Vujanic GM; Mehls O; Boos J; Beck J; Royer-Pokora B; Voûte PA Ann Oncol; 2004 May; 15(5):808-20. PubMed ID: 15111352 [TBL] [Abstract][Full Text] [Related]
13. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry. Dávila Fajardo R; Oldenburger E; Rübe C; López-Yurda M; Pritchard-Jones K; Bergeron C; Graf N; van Grotel M; van Tinteren H; Saunders D; van den Heuvel-Eibrink MM; Janssens GO; Oldenburger F Pediatr Blood Cancer; 2018 Aug; 65(8):e27085. PubMed ID: 29693799 [TBL] [Abstract][Full Text] [Related]
15. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM; J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843 [TBL] [Abstract][Full Text] [Related]
16. Bilateral Wilms tumors: Treatment results from a single center. Aydın B; Akyüz C; Yalçın B; Ekinci S; Oğuz B; Akçören Z; Yıldız F; Varan A; Kurucu N; Büyükpamukçu M; Kutluk T Turk J Pediatr; 2019; 61(1):44-51. PubMed ID: 31559721 [TBL] [Abstract][Full Text] [Related]
17. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience. Zekri W; Yacoub DM; Ibrahim A; Madney Y J Egypt Natl Canc Inst; 2020 May; 32(1):21. PubMed ID: 32372372 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of event-free survival in patients with Wilms tumor undergoing preoperative chemotherapy. Analysis of lymph-node yield in a single-center cohort. Flores P; Cadario M; Strambach J; Sanjuanelo M; Saleme JM; Paz E; Cacciavillano W; Felizzia G; Galluzzo L; Corbetta JP J Pediatr Urol; 2021 Apr; 17(2):227.e1-227.e5. PubMed ID: 33309612 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies. Breslow NE; Ou SS; Beckwith JB; Haase GM; Kalapurakal JA; Ritchey ML; Shamberger RC; Thomas PR; D'Angio GJ; Green DM Cancer; 2004 Sep; 101(5):1072-80. PubMed ID: 15329918 [TBL] [Abstract][Full Text] [Related]
20. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9. Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF Med Pediatr Oncol; 2000 Mar; 34(3):183-90. PubMed ID: 10696124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]